1. Home
  2. MRAM vs SGMO Comparison

MRAM vs SGMO Comparison

Compare MRAM & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$8.64

Market Cap

183.3M

Sector

Technology

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.50

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
SGMO
Founded
2008
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
183.3M
155.1M
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
MRAM
SGMO
Price
$8.64
$0.50
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$10.50
$4.71
AVG Volume (30 Days)
197.3K
9.3M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,642,000.00
$32,875,000.00
Revenue This Year
$11.00
$1.37
Revenue Next Year
$9.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$0.38
52 Week High
$12.27
$2.84

Technical Indicators

Market Signals
Indicator
MRAM
SGMO
Relative Strength Index (RSI) 50.52 51.55
Support Level $7.87 $0.42
Resistance Level $8.42 $0.55
Average True Range (ATR) 0.36 0.05
MACD 0.12 0.02
Stochastic Oscillator 84.08 67.23

Price Performance

Historical Comparison
MRAM
SGMO

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: